You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb386026 |
---|---|
Category | Antibodies |
Description | This antibody recognizes an epitope encoded by exon v9 on the variant portion of human CD44. The CD44 molecule belongs to a family of cellular adhesion molecules found on a wide range of normal and malignant cells in epithelial, mesothelial and hemopoiesis tissues. CD44 is a single gene with 20 exons, of which 10 are normally expressed to encode the basic CD44 (H-CAM) molecule. The additional 10 exons (v1 to v10) are only expressed by alternative splicing of the nuclear RNA. The expression of specific cell adhesion molecule CD44 splice variants has been reported to be associated with metastasis in certain human malignancies. |
Species/Host | Mouse |
Clonality | Monoclonal |
Clone Number | CD44v9/1459 |
Tested applications | IHC-P |
Reactivity | Human |
Isotype | Mouse IgG1, kappa |
Immunogen | An amino acid sequence from the variant 9 domain of CD44 was used as the immunogen for the CD44v9 antibody. |
Dilution range | Immunohistochemistry (FFPE): 1-2ug/ml for 30 min at RT |
Purity | Protein G affinity chromatography |
Conjugation | Unconjugated |
Formula | 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide |
Hazard Information | This CD44v9 antibody is available for research use only. |
UniProt ID | P16070 |
Storage | Store the CD44v9 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide). |
Buffer/Preservatives | 0.2 mg/ml in 1X PBS with 0.1 mg/ml rAlbumin (US sourced) and 0.05% sodium azide |
Note | For research use only |
Application notes | Titering of the CD44v9 antibody may be required for optimal performance. |
Expiration Date | 12 months from date of receipt. |
Immunohistochemical staining of Human cervical carcinoma using CD44v9 antibody
Immunohistochemical staining of Human prostate carcinoma using CD44v9 antibody
Immunohistochemical staining of Human tongue carcinoma using CD44v9 antibody
Filter by Rating